New Zealand medical device registration timeline

Source-linked clocks

Medsafe (Ministry of Health) (Medsafe) review clocks and end-to-end planning ranges, using the 4-class (I, IIa, IIb, III) — WAND notification-based system classification system.

1 pathways1 of 1 clocks verifiedvalidity Notification does not expire, but reg 8 requires corrections within 10 working days of any notified detail ceasing to be correctMDSAP not acceptedreviewed 2026-08-30legislation.govt.nz

Class / pathway	Review clock	Planning total	With prior approval	Provenance
All devices (WAND notification)(Notification to the Web Assisted Notification of Devices (WAND) database) Zero regulator decision time, at every risk class. WAND is a database, not an approval: there is no pre-market assessment, no fee, and no certificate, and a completed notification is confirmed on submission once the sponsor signs the declaration under reg 7	0 days	1-2 months	—	Verified

Review clocks exclude applicant hold time · planning totals are estimates

Planning steps and estimates; these are not regulator deadlines.

New Zealand Medical Device Registration Process

Step-by-step Medsafe registration process. Total estimated timeline: 1-2 months.

Step 1: Pre-Submission Preparation

1-3 months

Gather technical documentation, quality management system (QMS) records, and clinical data required by Medsafe. Appoint a New Zealand Sponsor.

Step 2: Application Submission

1-2 weeks

Submit complete registration dossier to Medsafe including device description, risk analysis, and testing reports.

Step 3: Administrative Review

2-4 weeks

Medsafe reviews application for completeness. May request additional documents or clarifications.

Step 4: Technical Evaluation

0 days

In-depth technical assessment of device safety and performance. Medsafe may issue questions.

Step 5: Registration Approval

1-2 weeks

Upon successful review, Medsafe issues New Zealand market authorization certificate.

Summary: The New Zealand medical device registration process through Medsafe (Ministry of Health) (Medsafe) consists of 5 main steps: Pre-Submission Preparation → Application Submission → Administrative Review → Technical Evaluation → Registration Approval.

Prior approval recognition

CE Mark (EU MDR)Neither required nor rewarded. WAND is a sponsor notification rather than an assessment: Medsafe does not review the device before it goes on the database, so there is no decision for a foreign approval to influence. The certificate matters as evidence the sponsor holds behind the notification.None — there is no review period to shorten

FDA 510(k)/PMASame position as a CE certificate: useful evidence for the sponsor, irrelevant to the notification itself.None — there is no review period to shorten

Key requirements

New Zealand sponsor (local representative) responsible for the WAND notification
Devices must be sourced from a country with an approved regulatory regime (e.g., EU MDR, FDA TGA-equivalent) or meet alternate-entry rules
Reg 9 requires the sponsor to have procedures in place that ensure compliance with regs 5, 6 and 8 — the obligation is a standing one, not a single filing
The pre-market regime that would have replaced this never arrived. The Therapeutic Products Act 2023 would have introduced full device regulation on 1 September 2026, but it was repealed on 18 December 2024 before commencing, so devices remain under the Medicines Act 1981 and the WAND regulations while a Medical Products Bill is drafted

Primary regulator sources

legislation.govt.nz · Medicines (Database of Medical Devices) Regulations 2003 — WAND notification duties medsafe.govt.nz · Medsafe — Regulatory Requirements for Sponsors: reg 6 requires notification within 30 working days of becoming the sponsor (read as running from the date the device first arrives in New Zealand), reg 8 requires corrections within 10 working days, reg 10 forbids treating notification as endorsement, and reg 14 makes contravention of regs 6, 8, 9 or 10 an offence fined up to $500 legislation.govt.nz · Therapeutic Products Act Repeal Act 2024 (2024 No 55) — repealed the Therapeutic Products Act 2023 on 18 December 2024 before its 1 September 2026 commencement, leaving devices under the Medicines Act 1981 and the WAND regulations

Reviewed 2026-08-30. End-to-end totals remain planning estimates.

Keep researching this market

View the New Zealand resource hub →

Compare timeline across all countries →

Continue with this market

Source-linked review clocks verified against Medsafe publications · full review 2026-08-30 · row IDs are stable — cite as registration-timeline:new-zealand:wand-notification